Familial pancreatic carcinoma: genes and variants
Explore variant evidence for Familial pancreatic carcinoma across 8 analyzed proteins (STK11, KRAS, PALB2, SMAD4, TP53 and 3 more). Linked ClinVar records include 4 pathogenic or likely pathogenic variants, 14 variants of uncertain significance and 11 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Counts refer to the selected disease label.
Data updated 2026-11-04. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Familial pancreatic carcinoma
STK11: Serine/threonine-protein kinase STK11
It activates AMPK-family kinases to coordinate cellular energy sensing, polarity, and growth restraint. Germline loss-of-function variants cause Peutz-Jeghers syndrome and its associated cancer predisposition, while somatic loss is common in lung and other cancers.
2 ClinVar pathogenic / likely pathogenic and 11 uncertain variants in STK11 have source records linked to Familial pancreatic carcinoma. Association strength is not clinical gene validity.
KRAS: GTPase KRas
A small GTPase that acts as a molecular switch in the RAS-MAPK signaling pathway. By cycling between GDP- and GTP-bound states, it relays growth and survival signals, and activating KRAS variants are common drivers of cancer.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in KRAS have source records linked to Familial pancreatic carcinoma. Association strength is not clinical gene validity.
PALB2: Partner and localizer of BRCA2
It physically links BRCA1 and BRCA2 and helps recruit BRCA2-RAD51 repair machinery to DNA double-strand breaks. Heterozygous loss-of-function variants substantially increase breast and pancreatic cancer risk, while biallelic variants cause Fanconi anemia subtype N.
0 ClinVar pathogenic / likely pathogenic and 6 uncertain variants in PALB2 have source records linked to Familial pancreatic carcinoma. Association strength is not clinical gene validity.
SMAD4: SMAD family member 4
It forms transcriptional complexes with activated receptor-regulated SMADs and is the central nuclear mediator shared by TGF-beta and BMP pathways. Germline loss-of-function variants cause juvenile polyposis or combined juvenile-polyposis-HHT, while specific gain-of-function variants cause Myhre syndrome.
0 ClinVar pathogenic / likely pathogenic and 5 uncertain variants in SMAD4 have source records linked to Familial pancreatic carcinoma. Association strength is not clinical gene validity.
TP53: Cellular tumor antigen p53
It coordinates transcriptional responses to DNA damage and other cellular stresses, promoting cell-cycle arrest, senescence, DNA repair, or apoptosis when appropriate. Loss of this tumor-suppressive control is one of the most common events in cancer, while germline pathogenic variants cause Li-Fraumeni syndrome.
0 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in TP53 have source records linked to Familial pancreatic carcinoma. Association strength is not clinical gene validity.
ATM: Serine-protein kinase ATM
It is activated by DNA double-strand breaks and coordinates checkpoint arrest, repair, and apoptosis through phosphorylation of numerous targets. Biallelic loss causes ataxia-telangiectasia, while heterozygous pathogenic variants increase susceptibility to several cancers.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in ATM have source records linked to Familial pancreatic carcinoma. Association strength is not clinical gene validity.
BRCA1: Breast cancer type 1 susceptibility protein
It coordinates DNA-damage signaling and homologous-recombination repair while helping protect stalled replication forks and chromosome integrity. Germline loss-of-function variants strongly predispose to breast and ovarian cancer and increase risk for several other malignancies.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in BRCA1 have source records linked to Familial pancreatic carcinoma. Association strength is not clinical gene validity.
BRCA2: Breast cancer type 2 susceptibility protein
It loads RAD51 onto damaged DNA to enable homologous recombination and also protects stressed replication forks from degradation. Germline loss-of-function variants strongly predispose to breast, ovarian, prostate, pancreatic, and other cancers.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in BRCA2 have source records linked to Familial pancreatic carcinoma. Association strength is not clinical gene validity.
Weakly linked (only a few uncertain records): CDKN2A.
ClinVar pathogenic and likely pathogenic variants linked to Familial pancreatic carcinoma
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| KRAS G13D | 13 | Pathogenic / likely pathogenic (★★) | |
| STK11 G163R | 163 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| STK11 W308L | 308 | Protein kinase | Pathogenic / likely pathogenic (★★) |
| KRAS A146V | 146 | Pathogenic / likely pathogenic |
Same protein, different disease
- Peutz-Jeghers syndrome also has ClinVar records linked to STK11 variants; they fall mostly in different places as the Familial pancreatic carcinoma variants (24 pathogenic / likely pathogenic).
- RASopathy also has ClinVar records linked to KRAS variants; they fall mostly in different places as the Familial pancreatic carcinoma variants (23 pathogenic / likely pathogenic).
- Noonan syndrome also has ClinVar records linked to KRAS variants; they fall mostly in different places as the Familial pancreatic carcinoma variants (16 pathogenic / likely pathogenic).
- Cardiofaciocutaneous syndrome also has ClinVar records linked to KRAS variants; they fall mostly in different places as the Familial pancreatic carcinoma variants (9 pathogenic / likely pathogenic).
- Autoimmune lymphoproliferative syndrome also has ClinVar records linked to KRAS variants; they fall in the same places as the Familial pancreatic carcinoma variants (5 pathogenic / likely pathogenic).
- Non-small cell lung carcinoma also has ClinVar records linked to KRAS variants; they fall mostly in different places as the Familial pancreatic carcinoma variants (5 pathogenic / likely pathogenic).
Diseases related to Familial pancreatic carcinoma
- Hereditary breast ovarian cancer syndrome, also linked to ATM, BRCA1, BRCA2, KRAS and 3 more
- Hereditary breast cancer, also linked to ATM, BRCA1, BRCA2, KRAS and 2 more
- Gastric cancer, also linked to ATM, KRAS, PALB2 and TP53
- Fanconi anemia complementation, also linked to BRCA1, BRCA2 and PALB2
- Ovarian cancer, also linked to ATM, BRCA1 and BRCA2
- Acute myeloid leukemia, also linked to KRAS, PALB2 and TP53
- Colorectal cancer, also linked to ATM, KRAS and TP53
- Urinary bladder cancer, also linked to ATM, KRAS and TP53
- Ovarian neoplasm, also linked to BRCA1, BRCA2 and TP53
- Lung adenocarcinoma, also linked to KRAS, STK11 and TP53
- Carcinoma of pancreas, also linked to SMAD4, STK11 and TP53
- Prostate cancer, hereditary, also linked to BRCA2, KRAS and TP53
Frequently asked questions
Which genes have records linked to Familial pancreatic carcinoma?
This view contains 8 analyzed proteins: STK11, KRAS, PALB2, SMAD4, TP53 and 3 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 4 pathogenic or likely pathogenic variants, 14 variants of uncertain significance and 11 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 35 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center